本页面由Tiger Trade Technology Pte. Ltd.提供服务

Entrada Therapeutics, Inc.

13.20
+0.50003.94%
成交量:27.33万
成交额:357.91万
市值:5.04亿
市盈率:-3.80
高:13.30
开:12.65
低:12.65
收:12.70
52周最高:13.30
52周最低:4.93
股本:3,821.92万
流通股本:2,158.20万
量比:0.86
换手率:1.27%
股息:- -
股息率:- -
每股收益(TTM):-3.4746
每股收益(LYR):-3.4746
净资产收益率:-39.13%
总资产收益率:-21.58%
市净率:1.65
市盈率(LYR):-3.80

数据加载中...

2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/01/08

重要事件披露

Form 8-K - Current report
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities